ArticleScientific reports2018

MiR-29c reduces the cisplatin resistance of non-small cell lung cancer cells by negatively regulating the PI3K/Akt pathway.

Dian-Min Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.